• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 CT 的影像组学特征无创预测卵巢癌 CXCL10 表达及预后

Radiomics Signatures Based on Computed Tomography for Noninvasive Prediction of CXCL10 Expression and Prognosis in Ovarian Cancer.

机构信息

Department of Gynecology and Obstetrics, Department of Gynecology, The Second Hospital of HeBei Medical University, Affiliated Hospital of Chengde Medical University, Shijiazhuang, China.

Department of Nuclear Medicine, Affiliated Hospital of Chengde Medical University, Chengde, China.

出版信息

Cancer Rep (Hoboken). 2024 Oct;7(10):e70030. doi: 10.1002/cnr2.70030.

DOI:10.1002/cnr2.70030
PMID:39443817
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11499071/
Abstract

BACKGROUND

Ovarian cancer (OC) is an aggressive gynecological tumor usually diagnosed with malignant ascites and even observed widespread metastasis or distant spread.

AIMS

We aimed to develop and identify radiomics models according to computed tomography (CT) for preoperative prediction of CXCL10 expression and prognosis in patients with OC.

METHODS

Genomic data with CT images and corresponding clinicopathological parameters were extracted from The Cancer Imaging Archive (TCIA) and The Cancer Genome Atlas (TCGA). To analyze the prognosis, we carried out the univariate Cox regression analysis (UCRA), multivariate Cox regression analysis (MCRA), and Kaplan-Meier (KM) analysis. For the data reduction, logistic regression, operator regression, least absolute shrinkage selection, radiomic feature construction, and feature selection were utilized. The predictive performance of the radiomic signatures was assessed using the analyses of the receiver operating characteristic (ROC) curve, decision curve (DCA), and precision-recall (PR) curve. To evaluate the correlation between the radiomic score (Rad-score) and CXCL10 expression, the Wilcoxon rank-sum test was applied.

RESULTS

Three radiomics models effectively predicted CXCL10 expression levels (AUC = 0.791, 0.748, and 0.718 for the set of training; AUC = 0.761, 0.746, and 0.701 for the set of validation). A higher Rad-score significantly correlated with upregulated CXCL10 expression.

CONCLUSION

CXCL10 expression can be predicted noninvasively and preoperatively via radiomic signatures based on contrast-enhanced CT images.

摘要

背景

卵巢癌(OC)是一种侵袭性妇科肿瘤,通常通过恶性腹水诊断,甚至观察到广泛的转移或远处转移。

目的

我们旨在根据计算机断层扫描(CT)开发和识别放射组学模型,以预测 OC 患者的 CXCL10 表达和预后。

方法

从癌症成像档案(TCIA)和癌症基因组图谱(TCGA)中提取带有 CT 图像和相应临床病理参数的基因组数据。为了分析预后,我们进行了单变量 Cox 回归分析(UCRA)、多变量 Cox 回归分析(MCRA)和 Kaplan-Meier(KM)分析。为了进行数据缩减,利用了逻辑回归、操作员回归、最小绝对收缩选择、放射组学特征构建和特征选择。使用接收者操作特征(ROC)曲线、决策曲线(DCA)和精度-召回(PR)曲线分析评估放射组学特征的预测性能。为了评估放射组学评分(Rad-score)与 CXCL10 表达之间的相关性,应用了 Wilcoxon 秩和检验。

结果

三个放射组学模型有效地预测了 CXCL10 表达水平(在训练集的 AUC 分别为 0.791、0.748 和 0.718;在验证集的 AUC 分别为 0.761、0.746 和 0.701)。较高的 Rad-score 与上调的 CXCL10 表达显著相关。

结论

通过基于增强 CT 图像的放射组学特征,可以非侵入性和术前预测 CXCL10 表达。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72c1/11499071/ea161ec096ce/CNR2-7-e70030-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72c1/11499071/970d507af411/CNR2-7-e70030-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72c1/11499071/9a67d488b7de/CNR2-7-e70030-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72c1/11499071/17f3aa7d975e/CNR2-7-e70030-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72c1/11499071/4c426079a3b0/CNR2-7-e70030-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72c1/11499071/e5397949c3fc/CNR2-7-e70030-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72c1/11499071/69c584e5cbe5/CNR2-7-e70030-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72c1/11499071/ef93c4f4b72b/CNR2-7-e70030-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72c1/11499071/ea161ec096ce/CNR2-7-e70030-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72c1/11499071/970d507af411/CNR2-7-e70030-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72c1/11499071/9a67d488b7de/CNR2-7-e70030-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72c1/11499071/17f3aa7d975e/CNR2-7-e70030-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72c1/11499071/4c426079a3b0/CNR2-7-e70030-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72c1/11499071/e5397949c3fc/CNR2-7-e70030-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72c1/11499071/69c584e5cbe5/CNR2-7-e70030-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72c1/11499071/ef93c4f4b72b/CNR2-7-e70030-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72c1/11499071/ea161ec096ce/CNR2-7-e70030-g004.jpg

相似文献

1
Radiomics Signatures Based on Computed Tomography for Noninvasive Prediction of CXCL10 Expression and Prognosis in Ovarian Cancer.基于 CT 的影像组学特征无创预测卵巢癌 CXCL10 表达及预后
Cancer Rep (Hoboken). 2024 Oct;7(10):e70030. doi: 10.1002/cnr2.70030.
2
Predicting CD27 expression and clinical prognosis in serous ovarian cancer using CT-based radiomics.基于 CT 影像组学预测浆液性卵巢癌中 CD27 的表达和临床预后
J Ovarian Res. 2024 Jun 22;17(1):131. doi: 10.1186/s13048-024-01456-7.
3
Computed tomography-based radiomics prediction of CTLA4 expression and prognosis in clear cell renal cell carcinoma.基于 CT 的影像组学预测肾透明细胞癌 CTLA4 表达和预后。
Cancer Med. 2023 Mar;12(6):7627-7638. doi: 10.1002/cam4.5449. Epub 2022 Nov 17.
4
CT-based machine learning radiomics predicts CCR5 expression level and survival in ovarian cancer.基于 CT 的机器学习放射组学预测卵巢癌 CCR5 表达水平和生存。
J Ovarian Res. 2023 Jan 3;16(1):1. doi: 10.1186/s13048-022-01089-8.
5
Development and validation of radiomics nomogram for metastatic status of epithelial ovarian cancer.基于影像组学的上皮性卵巢癌转移状态列线图模型的建立与验证
Sci Rep. 2024 May 30;14(1):12456. doi: 10.1038/s41598-024-63369-1.
6
CT radiomics prediction of CXCL9 expression and survival in ovarian cancer.CT 放射组学预测卵巢癌中 CXCL9 的表达和生存。
J Ovarian Res. 2023 Aug 30;16(1):180. doi: 10.1186/s13048-023-01248-5.
7
Radiomics for lung adenocarcinoma manifesting as pure ground-glass nodules: invasive prediction.肺腺癌纯磨玻璃结节的影像组学分析:侵袭性预测。
Eur Radiol. 2020 Jul;30(7):3650-3659. doi: 10.1007/s00330-020-06776-y. Epub 2020 Mar 11.
8
MR-based radiomics-clinical nomogram in epithelial ovarian tumor prognosis prediction: tumor body texture analysis across various acquisition protocols.基于磁共振成像的放射组学-临床列线图在卵巢上皮性肿瘤预后预测中的应用:不同采集方案的肿瘤体纹理分析。
J Ovarian Res. 2022 Jan 12;15(1):6. doi: 10.1186/s13048-021-00941-7.
9
A radiomics approach for automated diagnosis of ovarian neoplasm malignancy in computed tomography.一种基于放射组学的 CT 自动诊断卵巢肿瘤良恶性的方法。
Sci Rep. 2021 Apr 22;11(1):8730. doi: 10.1038/s41598-021-87775-x.
10
Application Values of 2D and 3D Radiomics Models Based on CT Plain Scan in Differentiating Benign from Malignant Ovarian Tumors.基于 CT 平扫的二维和三维放射组学模型在鉴别良恶性卵巢肿瘤中的应用价值。
Biomed Res Int. 2022 Feb 17;2022:5952296. doi: 10.1155/2022/5952296. eCollection 2022.

本文引用的文献

1
Hematoma expansion prediction: still navigating the intersection of deep learning and radiomics.血肿扩大预测:仍在深度学习与放射组学的交叉领域中探索。
Eur Radiol. 2024 May;34(5):2905-2907. doi: 10.1007/s00330-024-10586-x. Epub 2024 Jan 22.
2
Development and Validation of CT-Based Radiomics Signature for Overall Survival Prediction in Multi-organ Cancer.基于 CT 的放射组学特征模型的建立与验证:用于多器官癌症患者总生存期的预测
J Digit Imaging. 2023 Jun;36(3):911-922. doi: 10.1007/s10278-023-00778-0. Epub 2023 Jan 30.
3
Radiomic model to predict the expression of PD-1 and overall survival of patients with ovarian cancer.
预测卵巢癌患者PD-1表达及总生存期的放射组学模型。
Int Immunopharmacol. 2022 Dec;113(Pt A):109335. doi: 10.1016/j.intimp.2022.109335. Epub 2022 Oct 21.
4
Chemokine CXCL10 Modulates the Tumor Microenvironment of Fibrosis-Associated Hepatocellular Carcinoma.趋化因子 CXCL10 调节纤维相关型肝细胞癌的肿瘤微环境。
Int J Mol Sci. 2022 Jul 23;23(15):8112. doi: 10.3390/ijms23158112.
5
Cancer statistics, 2022.癌症统计数据,2022 年。
CA Cancer J Clin. 2022 Jan;72(1):7-33. doi: 10.3322/caac.21708. Epub 2022 Jan 12.
6
Screening of CXC chemokines in the microenvironment of ovarian cancer and the biological function of CXCL10.卵巢癌微环境中 CXC 趋化因子的筛选及 CXCL10 的生物学功能。
World J Surg Oncol. 2021 Nov 18;19(1):329. doi: 10.1186/s12957-021-02440-x.
7
Role of CXCL10 in the progression of in situ to invasive carcinoma of the breast.CXCL10 在乳腺原位癌向浸润性癌进展中的作用。
Sci Rep. 2021 Sep 9;11(1):18007. doi: 10.1038/s41598-021-97390-5.
8
Identification of CXCL10-Relevant Tumor Microenvironment Characterization and Clinical Outcome in Ovarian Cancer.卵巢癌中CXCL10相关肿瘤微环境特征鉴定及临床结局
Front Genet. 2021 Jul 27;12:678747. doi: 10.3389/fgene.2021.678747. eCollection 2021.
9
Risk Score Generated from CT-Based Radiomics Signatures for Overall Survival Prediction in Non-Small Cell Lung Cancer.基于CT的放射组学特征生成的风险评分用于非小细胞肺癌总生存预测
Cancers (Basel). 2021 Jul 19;13(14):3616. doi: 10.3390/cancers13143616.
10
Infiltration by CXCL10 Secreting Macrophages Is Associated With Antitumor Immunity and Response to Therapy in Ovarian Cancer Subtypes.CXCL10 分泌型巨噬细胞浸润与卵巢癌亚型的抗肿瘤免疫和治疗反应相关。
Front Immunol. 2021 Jun 18;12:690201. doi: 10.3389/fimmu.2021.690201. eCollection 2021.